These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21285937)

  • 1. Very late thrombosis of sirolimus-eluting stent despite dual antiplatelet therapy for 4 years in a patient with lung cancer.
    Jung HJ; Sir JJ; Lee HK; Kang YK; Song BG; Choi SK
    Minerva Cardioangiol; 2011 Feb; 59(1):113-6. PubMed ID: 21285937
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
    Kimura T; Morimoto T; Nakagawa Y; Tamura T; Kadota K; Yasumoto H; Nishikawa H; Hiasa Y; Muramatsu T; Meguro T; Inoue N; Honda H; Hayashi Y; Miyazaki S; Oshima S; Honda T; Shiode N; Namura M; Sone T; Nobuyoshi M; Kita T; Mitsudo K;
    Circulation; 2009 Feb; 119(7):987-95. PubMed ID: 19204304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent acute myocardial infarction after 32 months: very late stent thrombosis after sirolimus-eluting stent implantation.
    Hou XM; Qiu XB; Fang WY
    Chin Med J (Engl); 2009 Oct; 122(19):2399-400. PubMed ID: 20079148
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential benefits and risks of the use of dual antiplatelet therapy beyond 6 months following sirolimus-eluting stent implantation for low-risk patients.
    Nakagawa T; Hiasa Y; Hosokawa S; Minami T; Yano Y; Yoneda K; Mizobe M; Murakami N; Tobetto Y; Chen H; Miyazaki S; Mahara K; Ogura R; Miyajima H; Yuba K; Takahashi T; Kishi K; Ohtani R
    J Cardiol; 2011 May; 57(3):283-9. PubMed ID: 21429711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents.
    Eisenberg MJ; Richard PR; Libersan D; Filion KB
    Circulation; 2009 Mar; 119(12):1634-42. PubMed ID: 19289638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
    Ayyanathan S; Hersh D; Coplan NL; Garratt K
    Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late stent thrombosis after implantation of a sirolimus-eluting stent.
    Kerner A; Gruberg L; Kapeliovich M; Grenadier E
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):505-8. PubMed ID: 14624431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late thrombosis of sirolimus-eluting stent occurring in the perioperative period].
    Kato M
    Masui; 2011 Apr; 60(4):465-9. PubMed ID: 21520597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.
    Mohammad RA; Goldberg T; Dorsch MP; Cheng JW
    Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry).
    Claessen BE; Mehran R; Leon MB; Heller EA; Weisz G; Syros G; Mintz GS; Franklin-Bond T; Apostolidou I; Henriques JP; Stone GW; Moses JW; Dangas GD
    Am J Cardiol; 2011 Feb; 107(4):528-34. PubMed ID: 21195378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative drug-eluting stent thrombosis in a patient undergoing robotic prostatectomy.
    Sharma A; Berkeley A
    J Clin Anesth; 2009 Nov; 21(7):517-20. PubMed ID: 20006260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous subacute stent thrombosis of two sirolimus-eluting stents in a patient treated by ReoPro, thrombus aspiration and triple anti-platelet agents.
    Moon JY; Chung JW; Kim JH; Ahn YK; Jeong MH
    Int J Cardiol; 2008 Oct; 130(1):e25-9. PubMed ID: 17913268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation.
    Camenzind E; Wijns W; Mauri L; Boersma E; Parikh K; Kurowski V; Gao R; Bode C; Greenwood JP; Gershlick A; O'Neill W; Serruys PW; Jorissen B; Steg PG;
    Am Heart J; 2009 Dec; 158(6):902-909.e5. PubMed ID: 19958855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry).
    Planer D; Beyar R; Almagor Y; Banai S; Guetta V; Miller H; Kornowski R; Brandes S; Krakover R; Solomon M; Lotan C
    Am J Cardiol; 2008 Apr; 101(7):953-9. PubMed ID: 18359314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Rossini R; Musumeci G; Aprile A; Valsecchi O
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):49-61. PubMed ID: 20121564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late coronary stent thrombosis complicating urologic surgery.
    de Korte FI; van Werkum JW; Vijverberg PL; Ten Berg JM
    Eur Urol; 2008 Jul; 54(1):221-5; quiz 225. PubMed ID: 17964710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
    Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
    Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.